Report Categories
View AllRecent Articles
View All
AIDriven Drug Discovery Could Transform Search for Treatable Brain Conditions
Subramanian Swamy Calls for Immediate Ban on Cement Imports from Pakistan Citing Security Risks
Regeneron and Parabilis Medicines Forge 232 Billion Deal to Target Undruggable Proteins
Dating Startups Target Fake Profiles with New Verification Solutions
WSJs Heard on the Street Launches Eighth Annual StockPicking Contest
ABT Q1 2026 Earnings Slight EPS Miss Sends Stock Lower as Core Businesses Show Resilience
Intelligent Bio Solutions Inc INBS Q1 2025 Earnings WiderThanExpected Loss Amid Continued PreRevenue Stage
IMNN Q1 2026 Earnings Narrowing Losses Beat Street Expectations as Pipeline Progress Continues
Okeanis Eco Tankers Q1 2026 Earnings Strong EPS Beat Amid Challenging Market Conditions
OXM Q1 2026 Earnings EPS Misses Estimates by Wide Margin Shares Gain
Planet Green Holdings PLAG Slides 3 as Shares Test Critical Support at 150
Journey Medical DERM Holds Steady at 596 as Stock Consolidates Between Key Levels
Jasper Therapeutics JSPR Hovers Near Support as Biotech Sentiment Remains Cautious
Ellington Credit Company EARN Bounces Modestly Support Holds Near 457
Perpetua Resources Secures 29 Billion US Loan to Develop Idaho Critical Minerals Project
Eicher Motors Drives Premium Shift as Cost Pressures Mount on Royal Enfield Margins
Short Seller Left Denies Allegations in Ongoing Securities Fraud Trial
South Korea Deputy PM Warns AI Wealth Must Benefit Public Amid Samsung Labor Unrest
External Links
DeepSeek Panic Overstated US AI Giants May Weather Competitive Storm
CAVA Q1 2026 Earnings EPS Surpasses Estimates Amid Strong Operational Performance
KMPR Q1 2026 Earnings EPS Falls Short of Estimates as Underwriting Challenges Persist
PGEN Q1 2026 Earnings NarrowerThanExpected Loss Drives Stock Higher
Halozyme Therapeutics HALO Q1 2026 Earnings EPS Beat Highlights Strong Operational Execution
SOHOB Q2 2025 Earnings Preferred Stock Reports EPS of 021 Amid Steady Performance
BKD Q1 2026 Earnings EPS Misses Estimates as Senior Living Operator Navigates Cost Headwinds
USCB Q1 2026 Earnings EPS Surpasses Estimates Stock Edges Higher
WMB Q1 2026 Earnings EPS Falls Short of Estimates Stock Declines 26
Alto Ingredients Inc ALTO Q1 2026 Earnings Surprise Profit on Strong Cost Management and Improved Margins